SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >

Entest BioMedical Inc. (ENTB)

ENTB RSS Feed
Add ENTB Price Alert      Hide Sticky   Hide Intro
Moderator: sizzleweed
Search This Board:
Last Post: 12/10/2016 10:39:26 AM - Followers: 444 - Board type: Free - Posts Today: 1

                                     ENTB LATEST NEWS FROM JUNE 1, 2016:
http://www.barchart.com/headlines/story/8402740/entest-biomedical-inc-in-discussions-to-acquire-nanotechnology-delivery-system-for-cancer-therapy




 

http://www.entb.net


 

 

 

 

 

Company Information:                                                      
4700 Spring Street, Suite 304
La Mesa, Calif. 91942
Telephone: 619-644-3344
Fax: 619-330-2328
E-mail:
info@EntestBio.com

Web site: www.EntestBio.com

 

CIK 0001449447
 

ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines


 

In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)
 


Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).

Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.

Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.

Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.

 

Management: 

David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance



 

 

http://www.entb.net
 

 Recent News!

June 1, 2015

 http://www.marketwired.com/press-release/entest-biomedical-inc-discussions-acquire-nanotechnology-delivery-system-cancer-therapy-otc-pink-entb-2025182.htm

 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTB
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ENTB News: Annual Report (10-k) 11/23/2016 06:08:21 AM
ENTB News: Current Report Filing (8-k) 09/26/2016 06:04:39 AM
ENTB News: Quarterly Report (10-q) 06/20/2016 03:10:17 PM
PostSubject
#37750  Sticky Note http://www.barchart.com/headlines/story/8402740/entest-biomedical-inc-in-discuss sizzleweed 06/25/16 03:12:29 AM
#37917   Good to see u back on the ENTB ronrooster 12/10/16 10:39:26 AM
#37916   ENTB any idea what percentage of ENTB is sizzleweed 12/09/16 09:33:57 PM
#37915   Rooster, that's a he++ no on an IPO. JokersWild12 12/09/16 01:01:24 PM
#37914   I am holding ENTB long term as well. ronrooster 12/09/16 12:17:19 PM
#37913   I've been in this stock over 2 years, salesleader 12/08/16 05:43:55 PM
#37912   Wow! Insane amount of chatter but 3 Kbro13 12/08/16 04:22:15 PM
#37911   The company has put out some interesting news zigzagman 12/08/16 03:49:01 PM
#37910   Their site getting big buzz! http://zandertherapeutics.weebly.com/ budfoxhub 12/08/16 03:41:08 PM
#37909   Good to see Barchart.com's opinion on the chart zigzagman 12/08/16 02:46:52 PM
#37908   Stock getting big buzz! budfoxhub 12/08/16 02:40:43 PM
#37907   $ENTB is a BUY Barchart Technical Opinion easymoneylucy 12/08/16 02:40:41 PM
#37906   I think we will see a push during Cabroncita 12/08/16 02:39:18 PM
#37905   ENTB trending higher. I like it Robertscott 12/08/16 02:31:07 PM
#37904   Any kind of Volume could get this one zigzagman 12/08/16 02:28:23 PM
#37903   Ready for a power hour push! budfoxhub 12/08/16 02:16:41 PM
#37902   I found this article about NR2F6 on the zigzagman 12/08/16 01:54:17 PM
#37901   Stock is riding the 50ma higher here: budfoxhub 12/08/16 01:40:31 PM
#37900   ENTB's Zander Therapeutics, Inc. (a wholly owned subsidiary zigzagman 12/08/16 01:27:40 PM
#37899   Just 40k left on the ask stockman69 12/08/16 01:24:15 PM
#37898   Types of cancers commonly found in dogs include zigzagman 12/08/16 01:21:20 PM
#37897   .04's on their way! budfoxhub 12/08/16 01:13:50 PM
#37896   Looking for a strong push this afternoon, could stockman69 12/08/16 01:05:54 PM
#37895   Getting an increase in Volume on the weekly zigzagman 12/08/16 12:52:18 PM
#37894   Ready to go green! budfoxhub 12/08/16 12:52:00 PM
#37893   That is right Bud, I look forward to Cabroncita 12/08/16 12:51:12 PM
#37892   $ENTB Trader's Cheat Sheet https://www.barchart.com/stocks/quotes/ENTB/cheat-sh Cabroncita 12/08/16 12:45:09 PM
#37891   Sweet looking daily chart here! zigzagman 12/08/16 12:29:06 PM
#37890   Technical Analysis for $ENTB https://www.barchart.com/stocks/quotes/ENTB/techni Cabroncita 12/08/16 12:29:06 PM
#37889   $ENTB weekly chart, curling up, breaking out easymoneylucy 12/08/16 12:27:25 PM
#37888   $ENTB has han active status on the Nevada SOS! easymoneylucy 12/08/16 12:25:11 PM
#37887   $ENTB The Barchart Technical Opinion rating is a easymoneylucy 12/08/16 12:20:01 PM
#37886   The hourly chart is setting up to Breakout zigzagman 12/08/16 12:18:43 PM
#37885   That it is Bud...seeing a lot of bu Cabroncita 12/08/16 11:54:52 AM
#37884   That is great news Zig! I like Cabroncita 12/08/16 11:53:42 AM
#37883   Solid company Cab, should hit a lot of radars! budfoxhub 12/08/16 11:43:09 AM
#37882   Check out the latest Patent News from ENTB zigzagman 12/08/16 11:42:40 AM
#37881   A lot of great DD there Bud, thanks! Cabroncita 12/08/16 11:38:59 AM
#37880   $ENTB resides on OTC Pink Current Information tier Cabroncita 12/08/16 11:27:35 AM
#37879   “Between 15 million and 20 million dogs are zigzagman 12/08/16 11:22:00 AM
#37878   It sure is! Very nice site indeed JokersWild! Cabroncita 12/08/16 11:21:10 AM
#37877   Fantastic to see the new website for Zander(ENTB)! JokersWild12 12/08/16 11:17:50 AM
#37876   ENTB has completed pre-clinical research indicating that, by zigzagman 12/08/16 10:42:40 AM
#37875   Solid company here, much more to come http://zandertherapeutics.weebly.com/intel budfoxhub 12/08/16 10:24:31 AM
#37874   Entest BioMedical, Inc. is a biotechnology company dedicated zigzagman 12/08/16 10:04:03 AM
#37873   $ENTB low float should be pulling off a Robertscott 12/08/16 10:01:49 AM
#37872   I agree. ENTB is a bargain Robertscott 12/08/16 10:01:29 AM
#37871   ENTB's primary goal is to continue growing the zigzagman 12/08/16 09:56:20 AM
#37870   Entest BioMedical Inc. ($ENTB) is a majority owned Cabroncita 12/08/16 09:56:02 AM
#37869   Under .04 a steal here! budfoxhub 12/08/16 09:48:43 AM
#37868   Product Pipeline: Bone Marrow and Aplastic Anemia Therapy budfoxhub 12/08/16 09:38:37 AM
PostSubject